Position in VCEL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$59,577,582
+$6,599,448 QoQ
Shares Held
1,339,123
-18.7% QoQ
Ownership
2.62%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#11
of 317 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GENEVA CAPITAL MANAGEMENT LLC holds $131,080,821 across 2 Biotechnology names. VCEL ranks #2 (45.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
1,012,077 | $71,503,239 | |
| 2 | VCEL |
Vericel Corp
This page
|
1,339,123 | $59,577,582 |
All Filings in VCEL
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,577,582 | 1,339,123 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $52,978,134 | 1,646,818 | Shares | Other | 2026-05-06 | |
| 2025-12-31 | $65,780,366 | 1,826,725 | Shares | Other | 2026-02-12 | |
| 2025-09-30 | $61,250,217 | 1,946,305 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $75,948,643 | 1,784,927 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $60,939,497 | 1,365,744 | Shares | Other | 2025-05-09 | |
| 2024-12-31 | $60,389,358 | 1,099,788 | Shares | Other | 2025-02-06 | |
| 2024-09-30 | $46,660,308 | 1,104,386 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $31,396,050 | 684,308 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $35,330,162 | 679,165 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $16,842,211 | 472,963 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $14,587,199 | 435,179 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||